Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Euro Hypertension-2020

**Delegate @ $249 only**

Early bird registration is going to end soon.. Hurry up!!! Book your slots!!!
 

About Conference


Euro Hypertension-2020 proudly announces the "8th World Congress on Hypertension Primary Health Care and Public Health" which will be held during June 18-19, 2020 at Geneva, Switzerland, after the brand success of “World Congress on Hypertension and Cardiovascular Diseases”.

Euro Hypertension 2020 will lay a platform for all the scientists, world-class professors, and cardiologists, nephrologist, endocrinologist, psychiatrists, osteopathicians , bariatric,  nurses, healthcare professionals to discuss an approach for hypertension and diagnosis, treatment and prevention of elevated blood pressure.

Hypertension is fairly common among the human population and is oft en unregulated; however, uncontrolled increase in blood pressure leaves the individuals at risk to develop heart ailments. According to a report by the World Health Organization in 2018, 1.1 billion people in the world have a raised blood pressure and less than 1 in 5 have it under control. Treatment of cardiovascular disease often requires the administration of numerous medications for long periods of time to patients likely to be old and suffering from a range of co-morbid conditions. This Conference is dedicated to incite discussions that promote innovations and fresh perspectives to the existing research related to cardiovascular diseases and hypertension.

 

Why To Attend ?

Hypertension meet 2020 is a distinctive forum to assemble worldwide distinguished academics within the field of cardiology, nephropathy, neuropathy, endocrinology, psychiatry , public health professionals, scientists, educational scientists, industry researchers, scholars to exchange concerning state of the art analysis and provides the best chance to reach the biggest gathering of participants from round the world. Conduct displays, distribute and update information concerning the current state of affairs of hypertension treatment and their effects that leads to the downfall of the society. This 2-day event can surely profit and paves the way for the betterment of the globe. Broadly acclaimed speakers, the foremost recent researches and updates in hypertension are the key features of this event.

The benefits provided to the attendees are:

  • CME accreditation certificates will be provided to all speakers, delegates and students
  • Opportunity to meet world’s renowned at this CME event
  • Keynote forums by Prominent Physicians & Professors
  • Best platform for Global business and networking opportunities
  • Oral/Poster presentations by Young Researchers
  • Best poster award for students

 

Market Analysis

According to Statistics MRC, the Global Stroke Diagnostics and Therapeutics market is reckoned for $23,849.39 Million in 2017 and is estimated to reach $49,698.68 Million by 2026 growing at a CAGR of 8.5% during the forecast period.

Factors like technological advancement, a growing aging population, and people affected by diabetes, high blood pressure are favouring the market. On the other hand, increasing health expenditure, cardiovascular diseases and increasing tobacco users are supplying the market.

Hypertension is a chronic medical condition during which the blood pressure is elevated to an unsought level. Hypertension is a chronic disease, which means that a patient could need to require medications a day for the rest of his/her life. Thus, the demand for anti-hypertensive medication is property and can increase with a rise within the variety of target patients. Anti-hypertensive drugs were the second largest therapy area in 2011 with the worldwide sales worth of over USD 40 billion, according to the globe Preview 2018 report by valuate drug company.

Some of the key players contributing to the worldwide anti-hypertensive medication market include Novartis AG, Pfizer, Inc., Johnson & Johnson Ltd., Sanofi S.A., Lupin Limited, Ranbaxy Laboratories Limited, Merck & Co., Inc., Astra Zeneca Plc, Daiichi Sankyo Company Limited, and Takeda Pharmaceutical Company Limited.

This research report analyses this market counting on its market segments, major geographies, and current market trends. Geographies analysed under this analysis report include

  • North America
  • Asia Pacific
  • Europe
  • Rest of the World  

 

Sessions / Tracks

 Track 1: Heart Diseases & Heart failure

Hypertension is the systemic condition accompanying high blood pressure. This remains as one of the common medical problems. High blood pressure is a common condition in which the long-term force of the blood against the artery walls is high enough that it may eventually cause health problems, such as heart failure, chronic kidney disease, coronary artery disease, stroke, atrial fibrillation, vision loss, peripheral vascular disease and dementia. There are two types of high blood pressure, such as primary (essential) hypertension, it tends to develop gradually over many years whereas secondary hypertension tends to develop gradually over many years. People with high blood pressure may have symptoms of headache, shortness of breath, nosebleeds, dizziness, chest pain, visual changes, blood in the urine.

The risk factors of high blood pressure includes age, race, obesity, Family history, use of tobacco, high intake of salt and lower intake of potassium, stress and certain chronic conditions.

Recommended Conferences

Hypertension Meetings Europe 2020 | Cardiovascular Disease Meetings Europe 2020 | Stroke Meetings Europe| Hypertension Congress 2020 | Hypertension Conference 2020 | Hypertension Conferences Asia | Heart Congress | Hypertension Conference 2020 |  Hypertension conferences Lisbon | Cardiology congress 2020 | 4th International Hypertension Conference & Healthcare, September 10-11, 2020 Zurich, Switzerland | 5th International Conference on Hypertension & Healthcare Conference, October 18-19, 2020 Abu Dhabi, UAE | 3rd Conference on Hypertension and Cardiovascular Diseases Conference, August 20-21, 2020 Toronto, Canada| Heart Congress Lisbon | International Conference On Hypertension & Cardiology conference, October 01-03, 2019, Las Vegas, USA| Hypertension Beijing 2020, September 20-23, 2020 | Public Health Meetings 2020 | 4th European Forum on Hypertension, Gdynia, May 10-12, 2020 

Related Societies

Austrian Heart Foundation, British Cardiovascular Society, British Heart Foundation, British Hypertension Society, Irish Nurses Cardiovascular Association, European Society of Hypertension, European Stroke Organisation,  Albanian Society of Cardiology, Bosnia and Herzegovina Society of Hypertension, Society for Public Health Education, Global Public Health Program, Mental Health and Psycho-Social Support Network, Movement for Global Mental Health, Mental Health Innovation Network, Mental Health Worldwide, Centre for Global Mental Health, The World Health Organization Mental Health programme, World Federation for Mental Health, The Gulbenkian Global Mental Health Platform, IFRC Reference Centre for Psychosocial Support.

Track 2: Cardiac Nursing and Healthcare

Cardiac nursing is a registered nurse who specializes to work with patients who suffer from various conditions of the cardiovascular system. Cardiac nurses help to treat conditions such as unstable angina, cardiomyopathy, coronary artery disease, congestive heart failuremyocardial infarction and cardiac dysrhythmia under the direction of a cardiologist. Cardiac nurses also perform postoperative care on a surgical unit, stress test evaluations, cardiac monitoring, vascular monitoring, and health assessments. Cardiac nurses work in many different environments, including coronary care units (CCU), cardiac catheterization, intensive care units (ICU), operating theatres, cardiac rehabilitation centers, clinical research, cardiac surgery wards, cardiovascular intensive care units (CVICU), and cardiac medical wards.

 

Recommended Conferences

Hypertension Conferences Asia | Hypertension Conference 2020 | Stroke Meetings | Hypertension Meetings  2020 | Heart Failure Events  2020 |  Stroke Meeting Asia Pacific | Hypertension Congress 2020 | Hypertension Conference 2020 | Heart Congress Lisbon | Heart Congress | Hypertension Conference 2020 

Related Societies

American Association of Clinical Research Professionals, International Society of Hypertension, American College of Epidemiology, American Nurses Association, American Public Health Association, American School Health Association, Association of Environmental Health Academic Programs, Association of Occupational and Environmental Clinics, Association of Public Health Laboratories, Association of Schools and Programs of Public Health, American Society for Microbiology, European Society of Hypertension, National Environmental Health Association, Society for Public Health Education, Society for Public Health Education, Global Public Health Program, Mental Health and Psycho-Social Support Network.|

Track 3: Pediatric & Geriatric Cardiology

High blood pressure in children and adolescents is one of the most common problems that the children are facing. They may contribute to premature atherosclerosis and the early development of cardiovascular diseases. Pediatric hypertension can be either primary or secondary and they are categorized as prehypertension (between 90th to 95th percentile), stage 1 (95th to 99th percentile plus 5 mmHg) and stage 2 (≥ 99th percentile plus 5 mmHg) hypertension. People who are between 3 to 18 years of age, the prevalence of prehypertension and hypertension was found to be 3.4 % and 3.6 % respectively.  Normally a blood pressure values varies by age, sex, and height. Therefore, awareness has to be taken seriously for the diagnosis and treatment of hypertension.

Recommended Conferences

Heart Failure Congress Portugal 2020 | Hypertension Conference 2020 | Stroke Congress | Hypertension Conference 2020 | Heart Congress | Stroke Meetings  2020 | Cardiology Conference 2020, World Heart Disease Meetings USA | Stroke Meetings Europe 2020| Cardiology Conferences  | Cardiology Conferences 2020 | Heart Failure Conference | Hypertension Conference 2020 

Related Societies

Movement for Global Mental Health event, Mental Health Innovation Network, Mental Health Worldwide, Centre for Global Mental Health, The World Health Organization Mental Health programme, World Federation for Mental Health, The Gulbenkian Global Mental Health Platform, IFRC Reference Centre for Psychosocial Support, Sarah Boseley's global health blog + Maternal health, Maternal Health and Maternal Mortality, Rethinking maternal health, Public Health conference, Public Health Agency of Canada, Chinese Center for Disease Control and Prevention, Centre for Health Protection, National Center for disease control,  The Japanese Society of Hypertension.

 
Gestational hypertension or pregnancy-induced hypertension (PIH) is the development of high blood pressure greater than 140/90 mm Hg in a pregnant woman. It occurs after 20 weeks of gestation and leads to a serious condition called preeclampsia, also referred to as toxemia. Due to this condition, it may prevent the placenta from receiving enough blood, which can cause low birth weight in the baby.
 
The symptoms of gestational hypertension includes rapid weight gain, high blood pressure, protein in the urine, and swelling in the hands, feet, and face, severe headaches, a change in reflexes, reduced output of urine or no urine, abdominal pain, blood in the urine, dizziness, or excessive vomiting and nausea, spots before the eyes.
 
•           Chronic Hypertension
•           Gestational Hypertension
•           Preeclampsia
 
Recommended Conferences:
 
European Heart Failure Events | Stroke Congress | Hypertension Conference 2020 |  Heart Congress | Heart Disease Events | Cardiology Conferences  |  Hypertension Congress 2020| Heart Failure Congress Europe 2020 | Heart Congress Lisbon | Heart Failure Conference  |   Hypertension Conference 2020 | 23rd European Heart Failure Symposium, February 19-21, 2020 Lisbon, Portugal | 27th European Cardiology Congress, October 19-21, 2020 Rome Italy 
 
Related Societies:                                                                                                                                                  
 
American Society of Hypertension, American Association of Cardiovascular and Pulmonary Rehabilitation, Austrian Heart Foundation, British Cardiovascular Society, British Heart Foundation, Infectious Diseases, Norwegian Institute of Public Health, American College of Cardiology, Instituto Nacional de Salud, National Center for Disease Prevention and Control, Public Health Agency of Sweden, Centers for Disease Control, American Academy of Clinical Toxicology, American Academy of Pediatrics, American Association of Occupational Health Nurses (AAOHN), American Society of Preventive Cardiology.
 
 
Resistant hypertension is defined as uncontrolled blood pressure elevating to approximately (>140/90 mm Hg) after treatment with three or more antihypertensive drugs, such patients are more likely to have a secondary cause and has a high risk of end-organ damage. ACE inhibitor (or an angiotensin receptor blocker), a diuretic and a calcium channel blocker preclude resistant hypertension, which must be ruled out before a diagnosis can be made.
 
The prognosis of resistant hypertension is not known, however cardiovascular risk is beyond any doubt raised as patients usually have a history of long-standing, severe hypertension sophisticated by multiple different cardiovascular risk factors such as obesity, sleep apnea, diabetes, and chronic renal disorder. The diagnosing of resistant hypertension needs use of excellent blood pressure technique to verify persistently elevated blood pressure levels. Pseudo resistance, including lack of blood pressure management secondary to poor medication adherence or white coat hypertension, should be excluded.
 
Recommended Conferences:
 
Heart Failure Conference | Hypertension Conference 2020 | Hypertension Congress | Stroke Congress | Cardiology Conferences 2020 | Hypertension Conferences 2020  | Stroke Congress Europe | Hypertension Congress 2020 | Cardiology Workshops 2020 | Hypertension Conferences Asia | Hypertension Conference 2020
 
 
 
Related Societies:
 
American Association of Naturopathic Physicians, American Holistic Health Association, International Society for Clinical Laboratory Technology, American Association of Nurse Anesthetists, Society for Nutrition Education, American Occupational Therapy Association, American Society of Extra-Corporeal Technology, American Association of Colleges of Pharmacy, American Academy of Physician Assistants, Asian Pacific Society of Hypertension, Turkish Society of Hypertension and Atherosclerosis, Cameroon Heart Foundation, High Blood Pressure Research Council of Australia, British and Irish Hypertension Society, Bosnia and Herzegovina Society of Hypertension, Belorussian Scientific Society of Cardiologists, British Association of Nursing in Cardiovascular Care, European Society of Hypertension.
 
 
Sexual dysfunction is difficulty experienced by an individual during any stage of sexual activity, including physical pleasure, desire, arousal or orgasm. The common risk factors associated with sexual dysfunction for men and women including individual general health status, cardiovascular disease, other genitourinary disease, psychiatric/psychological disorders, diabetes mellitus, other chronic disease, and socio-demographic conditions.
 
During the treatment of hypertension, antihypertensive drugs such as diuretics, potassium sparring diuretics and β-blockers are used, which results in erectile dysfunction. Sexual dysfunction disorders may be classified into four types: orgasm disorders, sexual desire disorders, arousal disorders and pain disorders.
 
Recommended Conferences:
 
Heart Congress | Hypertension congress 2020 | Heart Disease Events | Heart Congress Lisbon | Hypertension Conferences Asia | Stroke Congress | Hypertension Conferences 2020 | Hypertension Congress 2020 | Cardiology Conferences 2020 | Hypertension Conferences Europe 2020 | Hypertension Conference 2020 | Cardiology Events | Hypertension Conference 2020 
 
Related Societies:
 
Moroccan Society of Cardiology, Norwegian Society of Cardiology, Saudi Heart Association, Netherlands Society of Hypertension, Portuguese Society of Hypertension, Slovenian Society of Cardiology, Spanish Society of Hypertension, British Cardiovascular Society, Swedish Society of Cardiology, Zurich Heart House, American Physical Therapy Association, National Board for Respiratory Care, Inc., American Association of Blood Banks, American Association for Clinical Chemistry, Health Sciences Communications Association, American Dental Association, American Public Health Organization, Association of Public Health Laboratories, American Society of Tropical Medicine and Hygiene, Member National Cardiac Societies.
 
 
Hypertension is an extremely common comorbid condition in diabetes which significantly reduces the risk of macrovascular and microvascular complications, including stroke, coronary artery disease, and peripheral vascular disease, retinopathy, nephropathy, and possibly neuropathy.  It majorly depends on obesity, age and ethnicity. The use of angiotensin-converting enzyme inhibitors may slow progression to kidney failure and cardiovascular mortality, but these agents are the preferred therapy for managing diabetes and hypertension.
 
Recommended Conferences
 
Hypertension Conference 2020 | Cardiology Meetings Asia 2020 | Hypertension Conferences 2020 | Stroke Congress | Cardiology Conferences 2020 | Hypertension Congress 2020 | Stroke Meeting Asia Pacific | Heart Disease Events  Europe 2020 | Cardiology Events USA | Hypertension Conferences USA | Heart Failure Conference
 
Related Societies:
 
Congenital Cardiac Anaesthesia Society, International Society of Hypertension, Primary Care Diabetes Society, Northwest Association of Cardiovascular and Pulmonary Rehabilitation, Hypertension Canada, Pulmonary Hypertension Association, Heart and Stroke Foundation of Canada, The Public Health Foundation, Pan American Health Organization, National Institutes of Health , Harvard T.H. Chan School of Public Health, Swiss Tropical and Public Health Institute, European Public Health Association, American Association of Public Health Physicians, Local health departments in the United States, National Association of County and City Health Officials, Russian Society of Cardiology.
 
 
Renal hypertension or renovascular hypertension is elevated blood pressure due to narrowing of the arteries that carry blood to the kidneys or the blockage in the arteries due to high cholesterol. This condition is also called renal artery stenosis. As a consequence of this condition the kidney organs release hormones to maintain a higher amount of sodium and water, which in turn causes blood pressure to rise. It is usually controlled by antihypertensive drugs or treatments like stenting, angioplasty and surgery on the blood vessels of the kidney.
 
Recommended Conferences:
 
Cardiology Meeting Asia Pacific | Heart Congress Lisbon | Stroke Congress | Heart Congress Lisbon | Hypertension event 2020 | Cardiology Events USA | Cardiology Events Middle East 2020 |  Hypertension Congress 2020 | Heart Failure Events Middle East | Stroke Meetings Middle East 2020
 
Related Societies:
 
United States Senate Committee on Public Health and National Quarantine, National Association for Public Health Policy, British Cardiovascular Society, European Public Health Alliance, Upper Midwest Preparedness and Emergency Response Learning Center, Action on Smoking and Health, Population Council, Agency for Toxic Substances and Disease Registry, European Society of Hypertension, European Parliament Committee on the Environment, Public Health and Food Safety, Southern African Hypertension Society, European Public Health Alliance, Irish Heart Foundation, Lebanese Society of Nephrology and Hypertension, Luxembourg Society of Cardiology.
 
 
Hypertensive heart disease refers to heart problems occurring due to elevated blood pressure that is present over an extended period of time. Without treatment of high blood pressure, symptoms of heart failure can develop. It may lead to the thickening of the muscles which ultimately results in the deficient of the oxygen, this may cause angina (chest pain). High blood pressure also ends up in thickening of the blood vessel walls. When combined with cholesterol deposits within the blood vessels, the chance of heart attack and stroke will increase. Hypertensive heart disease is that the leading cause of unwellness and death from high blood pressure.
 
Recommended Conferences:
 
Hypertension Congress Middle East 2020  | Heart Congress | Stroke Symposiums 2020 | World Hypertension 2020 | Heart Failure Congress 2020 |  Heart Failure Congress 2020 | Hypertension Conference 2020 | Hypertension Congress 2020 | Stroke Congress |  Hypertension Conferences USA | Cardiology Conference Asia 2020 | Heart Disease Congress Asia | Heart Congress USA 
 
Related Societies:
 
New Hampshire Hospital Association, Society for Health Systems, The International Society for Quality in Health Care, French Healthcare, French Public Health Agency, National Institute of Health and Medical Research, American College of Occupational and Environmental Medicine (ACOEM), ESC Member National Cardiac Societies, American Health Quality Association, American Dietetic Association, National Association of Emergency Medical Technicians, National Environmental Health Association, Healthcare Financial Management Association, National Society of Genetic Counsellors, ESC Member National Cardiac Societies, American College of Cardiology.
 
 
Hypertension is the single most important risk factor for stroke, doubling the risk of stroke for each 20 mm Hg increase in systolic blood pressure (SBP). Although reducing the blood pressure can lower stroke risk by 30% to 40%
 
In comparison with other antihypertensive agents, angiotensin receptor blockers (ARB) provide additional protection against stroke and other Cardiovascular diseases.
 
The strain hypertension weakens the blood vessels and predisposes them to damage, results in the blockage. This causes an ischemic stroke and hypertension is the most important cause of this type of stroke and also transient ischemic attacks.
 
Recommended Conferences:
 
Cardiology Meeting Asia Pacific | Cardiology Conference 2020 | Heart Congress USA | Stroke Conferences | Heart Disease Congress 2020 | Stroke Congress | Hypertension Conference 2020 | Hypertension Conference 2020 |
23rd European Pulmonary Hypertension Congress | February 19-21, 2020 Lisbon, Portugal | 3rd World Heart Congress, April 19-20, 2020 Amsterdam, Netherlands | 24th Annual Cardiologists Conference, June 11-13, 2020 Barcelona, Spain
 
Related Societies 
 
United States Senate Committee on Public Health and National Quarantine, European Society of Hypertension, University of Washington Department of Global Health, Women's Health Protective Association, Society for Social Medicine, Society for Research on Nicotine and Tobacco, British and Irish Hypertension Society, International Coalition for Trachoma Control, International Epidemiological Association, John Snow, Inc, Johns Hopkins Center for Health Security, Mekong Basin Disease Surveillance, Association of State and Territorial Health Officials, Southern African Hypertension Society, International Society of Hypertension
 
 
Obesity increases the risk of the development of hypertension. Obesity-associated arterial hypertension is characterized by stimulation of the sympathetic nervous system, reaction of the renin-angiotensin system, and sodium retention, among other abnormalities. Obesity is characterized with increased blood flow, vasodilatation, cardiac output, and hypertension. Although cardiac index does not increase, cardiac output and glomerular filtration rate do. However, renal sodium retention also increases, leading to the cause of hypertension.
 
Recommended Conferences
 
Hypertension Congress 2020| Stroke Congress 2020 | Hypertension Meetings 2020 | Stroke Meeting Asia Pacific | Heart Congress USA | Hypertension Conference 2020 |  Stroke Meetings USA| Heart Congress Portugal | World Heart Failure Congress | European Public Health Congress  | Hypertension Meetings Middle East | Frontiers in Cardiovascular Biology April 20-22, 2020 Austria Center, Vienna| Stroke Conferences | Asian Pacific Society of Cardiology Congress 2020 , May 17-20, 2020| Cardiology Conferences 2020
 
Related Societies 
 
Federal Biomedical Agency, George Institute for Global Health, Global Coalition Against Pneumonia, Global Health Security Initiative, Journal of the American Society of Hypertension, National Farm Medicine Center, National Obesity Observatory, National Obesity Observatory, Public Health Wales, Public Health Research Institute, Public Health Education and Health Promotion Section, Corporate Accountability International, Association of Pediatric Cardiology, Indonesian Society of Hypertension, Thai Hypertension Society,  Malaysian Society of Hypertension, Cardiometabolic Heart Congress, Chinese Society of Cardiology, Philippine Society of Hypertension, The Heart Association of Thailand, Turkish Society of Hypertension and Atherosclerosis, World Heart Federation.
 
 
The risk factors of hypertension are age, smoking, diet, alcohol, cholesterol level, diabetes, ethnicity, family history, obesity, sedentary lifestyle, medication, recreation drugs. Regular physical activity decreases the risk of cardiovascular disease including high blood pressure, diabetes, breast and colon cancer, and depression. The prevention of hypertension is possible based on correct lifestyle and nutrition, starting from childhood age. The mediation that are used to treat high blood pressure are Thiazide diuretics, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), calcium channel blockers, alpha blockers, alpha-beta blockers, beta blockers, aldosterone antagonists, renin inhibitors,  vasodilators, central-acting agents.
 
Recommended Conferences
 
Heart Failure Conference | Heart Congress Portugal | Cardiology Conferences 2020 | Stroke Congress 2020 | Stroke Congress Portugal |  Hypertension Meetings Middle East 2020 | Stroke Meetings Middle East 2020 |  Stroke Meeting Asia Pacific | Heart Congress USA | Heart Disease Events  Europe 2019 | ISH 2020 Scientific Meeting – Beijing, September 20-23, 2020 Beijing, China | 4th International 4 Corners of Cardiology Meeting, February 09-10, 2020 Melbourne, Australia 
 
Related Societies 
 
Maternal Health and Maternal Mortality, International Society of Hypertension, Rethinking maternal health, Society and Public Health, Public Health Agency of Canada , Chinese Center for Disease Control and Prevention, Centre for Health Protection, National Center for disease control, National Institute of Infectious Diseases, American Podiatric Medical Association, Association of Schools and Programs of Public Health, National Rural Health Association, British and Irish Hypertension Society, Society for Diagnostic Medical Sonographers, American College of Sports Medicine, American Art Therapy Association.
 
 
In 1991, the National High Blood Pressure Education Program (NHBPEP) estimated that in United States, 43.3 million adults had hypertension. Overall, approximately 20% of the world’s adults are estimated to have high blood pressure. The prevalence dramatically elevates in patients older than 60 years: In many countries, 50% of individuals in this age group have hypertension. Worldwide, approximately 1 billion people have hypertension, contributing to more than 7.1 million deaths per year.
 
National health surveys in various countries have shown a high prevalence of poor control of hypertension.  These studies have reported that prevalence of hypertension is 22% in Canada, of which 16% is controlled; it is 26.3% in Egypt, of which 8% is controlled; and it is 13.6% in China, of which 3% is controlled.
 
Recommended Conferences
 
Hypertension Congress 2020 | Stroke Congress 2020 | Hypertension Meetings 2020 | Stroke Meetings USA 2020 | Heart Disease Events USA |   Stroke Meeting 2020 Europe | Hypertension Meetings USA | Global Cardiology Meet 2020  |  Hypertension Conferences USA | 5th International Conference on Prehypertension| Frontiers in Cardiovascular Biology April 20-22, 2020 Austria Center, Vienna 
 
Related Societies 
 
American Society of Echocardiography,  American Society of Nuclear Cardiology, American Diabetes Association,  American Stroke Association, Inter-American Society of Hypertension,  Latin American Society of Hypertension, Brazilian Society of Hypertension, American Heart Association,  Austrian Heart Foundation, British Cardiovascular Society, British Heart Foundation, British Hypertension Society, Irish Nurses Cardiovascular Association, European Society of Hypertension, European Stroke Organisation,  Albanian Society of Cardiology.
 
Track 14: Cardiology
 
Cardiology is a branch of medicine dealing with disorders of the heart and also the parts of the circulatory system. The field includes medical diagnosis and treatment of coronary artery disease, heart failure, congenital heart defects, valvular heart disease and electrophysiology. The symptoms that indicates a heart problem includes, shortness of breath, changes in heart rate or rhythm, high blood pressure, dizziness, chest pains.
 
Recommended Conferences
 
Hypertension Meetings 2020 | Stroke Conferences | Hypertension Congress Asia | Hypertension Symposiums 2020 | Stroke Congress Portugal  | Hypertension Meetings 2020 | Hypertension Conferences Europe | Stroke Meeting 2020 Europe | Hypertension Conferences 2020 | Heart Congress Portugal | Hypertension Conference 2020 | Heart Disease Events  Europe 2020 
 
Related Societies 
 
Heart Foundation of Botswana, Hellenic Society of Hypertension, European Society of Hypertension, British Association of Crit,  Georgian Society of Cardiology, Association of State and Territorial Health Officials, Association of Schools of Public Health, California Association of Public Health Laboratory Directors, Caribbean Epidemiology Centre, Council of State and Territorial Epidemiologists. ESC Member National Cardiac Societies| National Association of County and City Health Officials, Latvian Society of Hypertension, Moldavian Society of Cardiology, Montenegro Society of Cardiology ical Care Nurses, Cardiology Society of Serbia, Sudanese Hypertension Society, Swedish Society of Hypertension, Stroke and Vascular Medicine, Estonian Society of Cardiology.
 
 
The term global means international. Thus Global mental health defines the international viewpoint on various aspects of mental health. Its overall aim is to strengthen mental health all over the world by providing information about the mental health conditions in all countries, and classifying mental health care requirements in order to develop economical interventions to fulfil those specific requirements. Global mental health puts priority on improving mental health and achieving fairness in mental health for all individuals worldwide by study, research and practice. Lately, the global mental health movement has met with some criticism. It has been labelled as a cover for the pharmaceutical companies searching for new consumers for psychiatric drugs. Mental disorders are considered as health conditions categorized by changes in state of mind, mood and behaviour that are associated with pain or potentially disability in working. Mental illness refers to all diagnosable mental disorders. Mental disorders are one of the most well-known causes for disability and may incorporate death in some cases. Approximately, one in four people in the world is somehow affected by mental or neurological disorder at some point in their lives. Although there is rise in interventions for treatment of mental disorders and awareness about mental disorders among people, the so called treatment gap is still very high. The treatment gap is estimated to be in between 76–85% for low- and middle-income countries and 35–50% for high-income countries.
 
Recommended Conferences
 
Stroke Meeting 2020 Europe | Hypertension Conferences 2020 | Hypertension Workshops 2020  | Hypertension Congress Middle East |  Hypertension Meetings 2020 | Stroke Congress 2020 | Hypertension Meetings 2020 | Hypertension Conferences USA | Events on Hypertension
Related Societies 
 
Association of Schools of Public Health, California Association of Public Health Laboratory Directors, Caribbean Epidemiology Centre, British and Irish Hypertension Society, Council of State and Territorial Epidemiologists, Health Care Society, Lebanon, Foundation of Healthcare Technologies Society, New Hampshire Hospital Association, Society for Health Systems, The International Society for Quality in Health Care, French Healthcare, French Public Health Agency, National Institute of Health and Medical Research.

Abstract Submission Criteria & Eligibility

PRESENTATION REQUIREMENTS:

Presenting authors are responsible for registration, hotel costs and travel.

Note: The accepted abstracts will receive an acceptance letter in the mail allowing them to register for the conference.

Abstracts will be compiled and conference books are made available to participants at the conference days.

Any presenter who is unable to attend should arrange for another qualified individual to present the paper in place of the speaker. If such a change is necessary, please notify the program manager

Bincy Matthews

Contact information:

Linkedin: https://www.linkedin.com/in/bincy-matthews-583735163/

Twitter: https://twitter.com/BincyMatthews

Mail @ eurohypertension@europemeet.com

SUBMISSION OPTIONS:

Oral paper presentations will have 25-30 minute time slot and be clustered by topic into sessions. The keynote session will have for 45-minute time slot, workshop/ special session will have 60-minute time slot and symposium will have 60-minute time slot followed by 5-minute question and answer session.

Graduate & Masters students are eligible to submit their abstracts under poster or oral.

Special certificates will be given to the Student ambassador, Moderators and Best poster award.

Ph.D. students are eligible to submit their abstract under special YRF (young researcher’s forum), poster and oral presentation category.

NOTE: YRF category includes short oral presentation; this offer is subjected mainly for Ph. D. students

Extended abstract: Submissions should utilize the Abstract Template. Papers submitted in this category may represent original empirical research, theoretical development, critiques or reviews.

Note: Affiliation, Photograph should be attached along with the abstract.

 

 

Past Conference Report

Euro Hypertension 2018 Organizing Committee would like to thank the Moderators of the conference – Dr. Yochai Birnbaum, Baylor College of Medicine, USA and Dr. Ehud Baron, X-Cardio Corp. KK, Japan.

The conference was initiated with a warm welcome note by Yochai Birnbaum and the Keynote forum lead by Ehud Baron, from X-Cardio Corp. KK, Japan.

The highlights of the meeting were the eponymous lectures, delivered by:

  • Sandeep Shah, Tarilian Laser Technologies and ViCardio & The Barts Heart Centre, UK
  • Nita Shah, Tarilian Laser Technologies and ViCardio, UK
  • Percia Bezerra, Nefroclínica Nephrocare, Brazil
  • Rola Bou Serhal, Lebanese University, Lebanon
  • Laura Marques de Azevedo, SPDM, Brazil
  • Mafalda Castelão, Hospital de Santa Maria, Portugal
  • Joao Brocas, Tarilian Laser Technologies Ltd (TLT), UK
  • Shashi Mawar, AIIMS, India
  • Foroohar Foroozan, Analog Devices Inc.(ADI), Canada
  • Wafaa Mahmoud Abdel-Rehim, Alexandria University, Egypt
  • Remigijus Zaliunas, Lithuanian University of Health Sciences, Lithuania
  • Yochai Birnbaum, Baylor College of Medicine, USA & Yumei Ye, University of Texas Medical Branch, USA
  • Wala Awad & Anas AbuZaitoun, An Najah National University, Palestine
  • Grace M. Egeland, Norwegian Institute of Public Health & University of Bergen, Norway
  • Le Fang, Zhejiang Provincial Center for Disease Control and Prevention, China
  • Ersin Akpinar, Cukurova University, Turkey
  • Marcello Finardi Peixoto, Federal University of Sao Paulo (UNIFESP), Brazil

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums at Hypertension 2018. We sincerely thank the Organizing Committee Members, Editorial Board Members of International Journals, Participants, Attendees and Media Partners for their gracious presence and generous support, without which the conference would not have reached the pinnacle of success. With the unique feedback from the conference, we would like to announce the commencement of the 8th World Congress on Hypertension Primary Care & Public Health during June18-19, 2020 at Geneva, Switzerland.

Let us meet again @ Geneva, Switzerland

To Collaborate Scientific Professionals around the World

Conference Date June 18-19, 2020

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by